Tekla Life Sciences Investors (HQL) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | - | - | - | - | - | - | - | - | - | - | - | - |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 44.95M | 9.19M | 15.67M | 26.97M | 1.93M | 19.05M | 7.27M | 12.87M | 26.06M | 13.78M | 20.09M | 1.31M |
| Gross Margin % | 93.52% | 78.99% | 86.12% | 91.24% | 100% | 87.81% | 71.43% | 80.57% | 89.77% | 83.51% | 88.99% | 100% |
| Gross Profit Growth % | 186.84% | - | - | 41.61% | -73.45% | 47.95% | -72.12% | -6.55% | 29.74% | 948.52% | 1683.11% | 32.9% |
| Operating Expenses | -20.39M | -123.64M | 62.91M | 38.42M | 2.87M | 14.95M | 38.87K | 15.9K | 15.22K | 45.82K | 14.01K | 2.63M |
| OpEx % of Revenue | -42.41% | -1062.77% | 345.66% | 129.96% | 148.76% | 68.9% | 0.38% | 0.1% | 0.05% | 0.28% | 0.06% | 200.24% |
| Selling, General & Admin | 0 | 743.17K | 2.74M | -1.97M | 2.87M | 1.44M | 1.56K | 1.65K | 1.56K | 1.43K | 1.32K | 2.63M |
| SG&A % of Revenue | - | 6.39% | 15.04% | -6.65% | 148.76% | 6.65% | 0.02% | 0.01% | 0.01% | 0.01% | 0.01% | 200.24% |
| Research & Development | - | - | - | - | - | - | - | - | - | - | - | - |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income | 65.34M | 132.83M | -47.23M | -11.45M | -940.75K | -28.31M | -76.3M | 32.97M | 31.56M | 92.87M | 30.19M | -1.32M |
| Operating Margin % | 135.93% | 1141.76% | -259.55% | -38.72% | -48.76% | -130.5% | -750.13% | 206.34% | 108.69% | 562.91% | 133.75% | -100.24% |
| Operating Income Growth % | 238.33% | - | - | 59.56% | 98.77% | -185.85% | -341.79% | -64.5% | 4.52% | 7151.14% | 2032.93% | 27.89% |
| EBITDA | 65.34M | 132.83M | -45.86M | -11.4M | 0 | -27.66M | -76.3M | 32.97M | 31.56M | 92.87M | 30.19M | 0 |
| EBITDA Margin % | 135.93% | 1141.76% | -251.99% | -38.57% | - | -127.5% | -750.12% | 206.34% | 108.69% | 562.91% | 133.75% | - |
| EBITDA Growth % | 242.48% | - | - | 58.76% | 100% | -183.88% | -341.78% | -64.5% | 4.52% | - | - | - |
| D&A (Non-Cash Add-back) | 0 | 0 | 1.38M | 43.81K | 940.75K | 651.14K | 844 | 1.06K | 1.01K | 825 | 232 | 1.32M |
| EBIT | 65.34M | 132.83M | -47.23M | -11.45M | -940.75K | -28.31M | -76.3M | 32.97M | 31.56M | 92.87M | 30.19M | -1.32M |
| Net Interest Income | 533.2K | 349.83K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -30.66M | 0 |
| Interest Income | 533.2K | 349.83K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30.66M | 0 |
| Other Income/Expense | - | - | - | - | - | - | - | - | - | - | - | - |
| Pretax Income | 65.34M | 132.83M | -47.23M | -11.45M | 33.8M | -28.31M | -76.3M | 32.98M | 31.55M | 92.86M | 30.19M | -31.38M |
| Pretax Margin % | 135.93% | 1141.76% | -259.55% | -38.73% | 1752.11% | -130.5% | -750.1% | 206.41% | 108.66% | 562.83% | 133.75% | -2387.72% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | 65.34M | 132.83M | -47.23M | -11.45M | 33.8M | -28.31M | -76.3M | 32.98M | 31.55M | 92.86M | 30.19M | -31.38M |
| Net Margin % | 135.93% | 1141.76% | -259.55% | -38.73% | 1752.11% | -130.5% | -750.1% | 206.41% | 108.66% | 562.83% | 133.75% | -2387.72% |
| Net Income Growth % | 238.33% | - | - | 59.55% | 144.3% | -185.82% | -341.85% | -64.48% | 4.49% | 395.97% | 177.21% | -164.81% |
| Net Income (Continuing) | 65.34M | 132.83M | -47.23M | -11.45M | 33.8M | -28.31M | -76.3M | 32.98M | 31.55M | 92.86M | 30.19M | -31.38M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 2.15 | 4.60 | -1.64 | -0.43 | 1.29 | -1.10 | -3.03 | 1.34 | 1.30 | 3.91 | 1.29 | -1.33 |
| EPS Growth % | 231.1% | - | - | 60.91% | 142.57% | -182.09% | -333.08% | -65.73% | 0.78% | 393.99% | 175% | -162.74% |
| EPS (Basic) | 2.15 | 4.60 | -1.64 | -0.43 | 1.29 | -1.10 | -3.03 | 1.34 | 1.30 | 3.91 | 1.29 | -1.33 |
| Diluted Shares Outstanding | 30.41M | 28.87M | 28.87M | 26.79M | 26.21M | 25.68M | 25.14M | 24.67M | 24.28M | 23.75M | 23.49M | 23.6M |
| Basic Shares Outstanding | 30.41M | 28.87M | 28.87M | 26.79M | 26.21M | 25.68M | 25.14M | 24.67M | 24.28M | 23.75M | 23.49M | 23.6M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |